
Prof. Tulio de Oliveira (KRISP) talks vaccines
Nick chats to the director at KZN Research Innovation and Sequencing Platform (KRISP) about the talk of a potential vaccine moving to phase 2 of trials
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.